AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer

AstraZeneca and Daiichi Sankyo get FDA approval for Datroway's expanded use in triple-negative breast cancer treatment. https://www.nasdaq.com/articles/azn-daiichis-datroway-wins-fda-nod-expanded-use-breast-cancer